Insider · CIK 0001709976
Brian M. Gallagher Jr.
Files at EFTR (eFFECTOR Therapeutics, Inc.). First filing -, latest -.
In brief
Brian M. Gallagher Jr. files SEC Form 4 as director at EFTR (eFFECTOR Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Brian M. Gallagher Jr. has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 19, 2024 | EFTR eFFECTOR Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +2,000 | $0.00 | $0 | 2,000 | Feb 21, 2024 |
Questions about Brian M. Gallagher Jr.
Answered from the filings on this page, as of the latest one.
Is Brian M. Gallagher Jr. buying or selling?
Brian M. Gallagher Jr. has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Brian M. Gallagher Jr.'s past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Brian M. Gallagher Jr. has 0.
Where does Brian M. Gallagher Jr. file Form 4?
Brian M. Gallagher Jr. has filed Form 4 at EFTR (eFFECTOR Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.